Hepion Pharmaceuticals Inc (HEPA)
0.68
-0.01
(-1.45%)
USD |
NASDAQ |
Sep 27, 16:00
0.661
-0.02
(-2.79%)
After-Hours: 20:00
Hepion Pharmaceuticals Net Income (Annual): -48.93M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -48.93M |
| December 31, 2022 | -42.20M |
| December 31, 2021 | -32.72M |
| December 31, 2020 | -20.35M |
| December 31, 2019 | -7.037M |
| December 31, 2018 | -9.449M |
| Date | Value |
|---|---|
| December 31, 2017 | -7.511M |
| June 30, 2017 | -14.89M |
| June 30, 2016 | -17.00M |
| June 30, 2015 | -14.35M |
| June 30, 2014 | -5.281M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-48.93M
Minimum
2023
-7.037M
Maximum
2019
-30.25M
Average
-32.72M
Median
2021
Net Income (Annual) Benchmarks
| MEI Pharma Inc | 17.78M |
| Mira Pharmaceuticals Inc | -11.98M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -27.54M |
| iBio Inc | -24.91M |